Cited by 94Attention Deficit Hyperactivity DisorderSubstance Abuse Treatment and OutcomesSchizophrenia research and treatment

Prevalence, Patient Characteristics, and Pharmacological Treatment of Children, Adolescents, and Adults Diagnosed With ADHD in Sweden

Giacobini, MaiBritt, Medin, Emma, Ahnemark, Ewa, Russo, Leo J., Carlqvist, Peter·2018·Journal of Attention Disorders

Abstract

Objective: The objective of this study was to describe the epidemiology of diagnosed ADHD and the pharmacological treatment of patients with ADHD in Sweden. Specifically, this study estimates the prevalence of patients with a newly registered diagnosis of ADHD over a 5-year period, and the prevalence of all patients with a registered ADHD diagnoses over a 6-year period in Sweden. Method: Two population-based registries were used as data sources for this study; the National Patient Register (NPR) and the Prescribed Drug Register (PDR). The international Classification of Diseases 10th Revison (ICD-10) was used to identify patients with ADHD. Results: The annual prevalence of ADHD in the general population of Sweden was found to be 1.1 per 1,000 persons in the year 2006 increasing to 4.8 per 1,000 persons in 2011. The corresponding prevalence for newly diagnosed patients increased from 0.6 per 1,000 persons in 2007 to 1.3 per 1,000 persons in 2011. The majority of diagnosed patients received pharmacological treatment, with methylphenidate being the most common dispensed drug. Comorbidities in the autism spectrum were most common for younger patients, while substance abuse, anxiety, and personality disorder were the most common comorbidities in older patients. Conclusion: From 2006 to 2011, the number of patients diagnosed with ADHD has increased in Sweden over all ages. The majority of patients diagnosed with ADHD in Sweden received a pharmacological treatment regardless of age. An ADHD diagnosis was often accompanied with psychiatric comorbidity.

Integrity signals

Registry

Crossref · 10.1177/1087054714554617

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Giacobini, M., Medin, E., Ahnemark, E., Russo, L. J., & Carlqvist, P.
Affiliations
  • PRIMA Barn och Vuxenpsykiatri AB, Stockholm, Sweden
  • Karolinska Institutet (SE)
  • Shire (Sweden) (SE)
  • Takeda (United States) (US)
  • PAREXEL, Stockholm, Sweden
Corresponding author
Carlqvist, Peter
Venue
Journal of Attention Disorders
Published
2014-11-05
Volume
22
Issue
1
Pages
3-13
ISSN
  • 1087-0547 (ISSN-L)
  • 1557-1246
OpenAlex
W2028949171
Cited by
94
References
32
Citations by year
2026: 3 · 2025: 5 · 2024: 11 · 2023: 13 · 2022: 8 · 2021: 15 · 2020: 12 · 2019: 4 · 2018: 6 · 2017: 4 · 2016: 9 · 2015: 3 · 2013: 1
FWCI
4.07
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Attention Disorders (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Keywords
attention deficit hyperactivity disorder, prevalence, newly diagnosed patients, pharmacotherapy, methylphenidate, comorbidities, autism spectrum disorder, substance abuse, anxiety, personality disorders, children and adolescents, adults, Sweden
MeSH terms
Autism Spectrum Disorder, Adolescent, Adult, Anxiety Disorders, Attention Deficit Disorder with Hyperactivity, Child, Child, Preschool, Cross-Sectional Studies, Female, Humans, Infant, Newborn, Male, Methylphenidate, Drug Prescriptions, Registries, Sweden, Comorbidity, Prevalence, Age Distribution, Substance-Related Disorders, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review